
Waystar (WAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Waystar Holding Corp. The company is headquartered in Lehi, Utah.
| Revenue (TTM) | $1.16B |
| Gross Profit (TTM) | $794.87M |
| EBITDA | $413.98M |
| Operating Margin | 25.60% |
| Return on Equity | 3.57% |
| Return on Assets | 3.31% |
| Revenue/Share (TTM) | $6.33 |
| Book Value | $20.54 |
| Price-to-Book | 1.14 |
| Price-to-Sales (TTM) | 3.77 |
| EV/Revenue | 5.04 |
| EV/EBITDA | 14.10 |
| Quarterly Earnings Growth (YoY) | 37.50% |
| Quarterly Revenue Growth (YoY) | 22.40% |
| Shares Outstanding | $191.81M |
| Float | $139.70M |
| % Insiders | 1.48% |
| % Institutions | 110.58% |
Volatility is currently contracting

Waystar (WAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

LEHI, Utah and LOUISVILLE, Ky., July 1, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that it will host an Investor Day on Tuesday, August 25, 2026, in San Antonio, Texas, from 1:00 p.m.

Waystar Holding Corp. is rated buy, with an 85% upside to a $37 price target, as current share price reflects temporary private equity (PE) selling pressure, not business fundamentals. Waystar's revenue grew 22% YoY, profit margins remain above 40%, and a $200M buyback offsets PE overhang; 23 of 24 analysts rate it Buy/Strong Buy. The Iodine acquisition and AI-powered AltitudeAI suite expand WAY's end-to-end billing solutions, driving new client wins and high retention in a $100B+ addressable market.

Healthcare leaders show unanimous interest in a single AI-powered platform connecting the mid-cycle to the final claim — yet 86% are still leaving revenue on the table LEHI, Utah and LOUISVILLE, Ky., June 9, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today released The State of the Mid-Revenue Cycle report.

WAY's AI-driven RCM growth and strong Q1 results stand out, while TruBridge trades near its pending buyout price with limited upside.

LEHI, Utah and LOUISVILLE, Ky., May 20, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins will speak at the 46th Annual William Blair Growth Stock Conference on Tuesday, June 2, 2026, at 10:40 a.m.

Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution.

LEHI, Utah and LOUISVILLE, Ky., May 19, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that its Board of Directors authorized a stock repurchase plan for up to $200 million of the Company's common stock.

Waystar remains a buy as Q1 results confirm robust demand, with provider solutions leading and AI integration strengthening the platform story. WAY's Q1 revenue grew 22% y/y to $313.9M, with subscription revenue up 38% and net revenue retention at 111%, highlighting strong customer engagement. Patient payment solution headwinds stem from a faster shift to digital, seen as a near-term timing issue rather than a structural demand problem.

Wins TIME Impact in AI Award for purpose-built innovation in healthcare LEHI, Utah and LOUISVILLE, Ky., May 5, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced it has been named to the TIME100 Most Influential Companies list and recognized as the TIME Impact in AI award winner for delivering proven outcomes across the healthcare revenue cycle.